Reed Johnson F, Sheehan J, Ozdemir S, Wallace M, Yang J
Pharmacoeconomics. 2024; 43(1):45-52.
PMID: 39367175
DOI: 10.1007/s40273-024-01437-0.
Muir J, Radhakrishnan A, Freitag A, Ozer Stillman I, Sarri G
Front Pharmacol. 2023; 14:1197259.
PMID: 37521458
PMC: 10372435.
DOI: 10.3389/fphar.2023.1197259.
Oyewole O, Ale A, Ogunlana M, Gurayah T
World J Clin Cases. 2023; 11(14):3128-3139.
PMID: 37274052
PMC: 10237122.
DOI: 10.12998/wjcc.v11.i14.3128.
Reed Johnson F, Gonzalez J, Sheehan J, Reed S
Pharmacoeconomics. 2023; 41(8):845-856.
PMID: 37133682
DOI: 10.1007/s40273-023-01266-7.
Zhang M, Bao Y, Yang Y, Kimber M, Levine M, Xie F
Pharmacoeconomics. 2023; 41(4):439-455.
PMID: 36729295
PMC: 9893981.
DOI: 10.1007/s40273-022-01235-6.
Outcome measures for economic evaluations and cost-effectiveness analyses of interventions for people with intellectual disabilities: A methodological systematic review.
Benedetto V, Filipe L, Harris C, Tahir N, Doherty A, Clegg A
J Appl Res Intellect Disabil. 2022; 36(2):230-240.
PMID: 36448370
PMC: 10099878.
DOI: 10.1111/jar.13056.
Economic evaluation of microbiological and host biomarker-based tests for the diagnosis of pleural tuberculosis in a high burden setting.
Pooran A, Randall P, Meldau R, Maine R, Esmail A
J Thorac Dis. 2022; 14(9):3167-3177.
PMID: 36245620
PMC: 9562520.
DOI: 10.21037/jtd-22-106.
Calculating Utilities From the Neck Disability Index Score: Quantifying the Value of Care For Cervical Spine Pathology.
Jiang E, Castle J, Fisk F, Taliaferro K, Pahuta M
Global Spine J. 2022; 14(2):526-534.
PMID: 35938309
PMC: 10802524.
DOI: 10.1177/21925682221114284.
Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?.
Postma M, Noone D, Rozenbaum M, Carter J, Botteman M, Fenwick E
Orphanet J Rare Dis. 2022; 17(1):157.
PMID: 35382853
PMC: 8981887.
DOI: 10.1186/s13023-022-02283-z.
Evaluating the Benefits of New Drugs in Health Technology Assessment Using Multiple Criteria Decision Analysis: A Case Study on Metastatic Prostate Cancer With the Dental and Pharmaceuticals Benefits Agency (TLV) in Sweden.
Angelis A
MDM Policy Pract. 2022; 3(2):2381468318796218.
PMID: 35187241
PMC: 8855406.
DOI: 10.1177/2381468318796218.
Evaluating Montréal's harm reduction interventions for people who inject drugs: protocol for observational study and cost-effectiveness analysis.
Panagiotoglou D, Abrahamowicz M, Buckeridge D, Caro J, Latimer E, Maheu-Giroux M
BMJ Open. 2021; 11(10):e053191.
PMID: 34702731
PMC: 8549659.
DOI: 10.1136/bmjopen-2021-053191.
Data on Utility in Cost-Utility Analyses of Genetic Screen-and-Treat Strategies for Breast and Ovarian Cancer.
Simoes Correa Galendi J, Vennedey V, Kentenich H, Stock S, Muller D
Cancers (Basel). 2021; 13(19).
PMID: 34638366
PMC: 8508224.
DOI: 10.3390/cancers13194879.
A benefit-cost analysis of different response scenarios to COVID-19: A case study.
Cook D, Fraser R, McKirdy S
Health Sci Rep. 2021; 4(2):e286.
PMID: 34136653
PMC: 8177900.
DOI: 10.1002/hsr2.286.
How to Value Orphan Drugs? A Review of European Value Assessment Frameworks.
Blonda A, Denier Y, Huys I, Simoens S
Front Pharmacol. 2021; 12:631527.
PMID: 34054519
PMC: 8150002.
DOI: 10.3389/fphar.2021.631527.
A Meta-Regression Analysis of Utility Weights for Breast Cancer: The Power of Patients' Experience.
Gong J, Han J, Lee D, Bae S
Int J Environ Res Public Health. 2020; 17(24).
PMID: 33333997
PMC: 7765456.
DOI: 10.3390/ijerph17249412.
Health economic evaluation of gene replacement therapies: methodological issues and recommendations.
Aballea S, Thokagevistk K, Velikanova R, Simoens S, Annemans L, Antonanzas F
J Mark Access Health Policy. 2020; 8(1):1822666.
PMID: 33144927
PMC: 7580851.
DOI: 10.1080/20016689.2020.1822666.
Cost-Effectiveness of a Weight Loss Intervention: An Adaptation of the Look AHEAD Lifestyle Intervention in the US Military.
Manz K, Waters T, Clifton H, Kocak M, Klesges R, Talcott G
Obesity (Silver Spring). 2019; 28(1):89-96.
PMID: 31773873
PMC: 6925346.
DOI: 10.1002/oby.22681.
Cost-effectiveness of Housing First Intervention With Intensive Case Management Compared With Treatment as Usual for Homeless Adults With Mental Illness: Secondary Analysis of a Randomized Clinical Trial.
Latimer E, Rabouin D, Cao Z, Ly A, Powell G, Adair C
JAMA Netw Open. 2019; 2(8):e199782.
PMID: 31433483
PMC: 6707012.
DOI: 10.1001/jamanetworkopen.2019.9782.
Patient Preferences for Breast Cancer Treatment Interventions: A Systematic Review of Discrete Choice Experiments.
Guerra R, Castaneda L, Albuquerque R, Ferreira C, Correa F, Alves Fernandes R
Patient. 2019; 12(6):559-569.
PMID: 31321706
DOI: 10.1007/s40271-019-00375-w.
The status of health economic evaluation within decision making in Austria.
Zechmeister-Koss I, Stanak M, Wolf S
Wien Med Wochenschr. 2019; 169(11-12):271-283.
PMID: 30868427
PMC: 6713695.
DOI: 10.1007/s10354-019-0689-8.
